Research
Hormonal
Ketogenic diets significantly improve glycemic control and reduce insulin requirements in patients with Type 2 Diabetes, allowing for medication discontinuation or reduction in a subset of patients.
If you have Type 2 Diabetes, a ketogenic diet (<20g carbs/day) can significantly lower your HbA1c and reduce your need for medication. However, you must work with your doctor to adjust your insulin or oral medications to avoid dangerous hypoglycemia. Do not stop medications abruptly without monitoring your blood glucose.
GoodSupportsHIGH confidence
At the end of the 16-week timeframe, HbA1c decreased from 7.5 ±1.4% to 6.3 ±1.0% (p<0.001)... Furthermore, seven participants had their baseline diabetic medications discontinued, 10 participants had their baseline medications decreased, while four participants had unchanged requirements regarding baseline medications
Why this rating
Supported by RCTs and observational studies cited, though sample sizes are small.
Source
Advantages and Disadvantages of the Ketogenic Diet: A Review Article
Jennifer T Batch et al. · Cureus · 2020
DOI 10.7759/cureus.9639
narrative_reviewCited 177×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Ketogenic diets increase LDL cholesterol and total cholesterol, which may accelerate atherosclerosis and increase cardiovascular disease risk, despite improving triglycerides and HDL.Good
- Adherence to a ketogenic diet for 6-12 months produces transient improvements in weight loss, blood pressure, triglycerides, and HbA1c, but these benefits typically diminish and lose statistical significance after 12 months.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →